Clinical Trial Update: Compare the Accuracy of ctDNA-MRD and MVI Result in Predicting Postoperative Recurrence of Hepatocellular Carcinoma

View source ↗

Summary

A ClinicalTrials.gov entry for a study evaluating whether ctDNA-MRD and microvascular invasion can more accurately predict postoperative recurrence in hepatocel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Zhujiang Hospital | Conditions: Hepatocellular Carcinoma Resectable, Surgery | Status: NOT_YET_RECRUITING